Skip to main content

Table 3 Availability of Therapeutic Modalities in neonatal departments Settings

From: A nationwide survey on neonatal medical resources in mainland China: current status and future challenges

Modality

Total

NICU size (No. of beds)

P

 

(n = 117)

1–20 (n = 23)

21–50 (n = 47)

51–100 (n = 27)

> 100 (n = 20)

 

HFOV

82 (70.1)

8 (34.8)

31 (66.0)

25 (92.6)

18 (90.0)

< 0.01

Inhaled nitric oxide therapy*

36 (30.8)

0 (0)

7 (14.9)

14 (51.9)

15 (75.0)

< 0.01

PS replacement

112 (95.7)

20 (87.0)

45 (95.7)

27 (100)

20 (100)

0.093

Exsanguination transfusion

100 (85.5)

10 (43.5)

44 (93.6)

26 (96.3)

20 (100)

< 0.01

Umbilical venous catheter

67 (57.3)

5 (21.7)

23 (48.9)

21 (77.8)

18 (90.0)

< 0.01

PICC

92 (78.6)

12 (52.2)

35 (74.5)

26 (96.3)

19 (95.0)

< 0.01

Hypothermia*

36 (30.6)

0 (0)

10 (21.3)

15 (55.6)

12 (60.0)

< 0.01

Fundus screening

91 (77.8)

9 (39.1)

39 (83.0)

23 (85.2)

20 (100)

< 0.01

ROP laser therapy*

26 (22.2)

1 (4.3)

7 (14.9)

8 (29.6)

10 (50.0)

< 0.01

Bedside ultrasound

100 (85.5)

13 (56.3)

42 (89.4)

25 (92.6)

20 (100)

< 0.01

Neonatal surgery*

73 (62.4)

1 (4.3)

32 (68.1)

23 (85.2)

17 (85.0)

< 0.01

Peritoneal dialysis*

33 (28.2)

0 (0)

8 (17.0)

13 (48.1)

12 (60.0)

< 0.01

CRRT*

16 (13.7)

1 (4.3)

3 (6.4)

4 (14.8)

8 (40.0)

< 0.01

ECMO*

5 (4.3)

0 (0)

0 (0)

2 (7.4)

3 (15.0)

0.028

Neonatal transport

81 (69.2)

9 (39.1)

31 (66.0)

21 (77.8)

20 (100)

< 0.01

  1. Pearson’s χ2 test was used for bivariate comparison of proportions. * used Fisher’s exact test